Solid Organ Transplant Recipients with Pretransplant Cancer Have an Elevated Risk of Posttransplant Cancer of the Same Cancer Type By Ogkologos - March 30, 2026 224 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Transplant Cancer Match Study Source RELATED ARTICLESMORE FROM AUTHOR Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years for Patients with Metastatic Hormone-Sensitive Prostate Cancer Metastatic Breast Cancer: ESMO Living Guideline EMA Recommends Extension of Indications for Datopotamab Deruxtecan MOST POPULAR Osimertinib After Definitive Chemoradiotherapy Prolongs PFS in Patients with Unresectable Stage... June 6, 2024 Nivolumab: Μία σημαντική θεραπευτική επιλογή November 3, 2019 Flame of Hope Awards: Celebrating our volunteers April 3, 2023 How We’re Working to Build a Cancer Survivorship Community: Survivors’ Perspectives December 14, 2023 Load more HOT NEWS Cómo prepararse para su exploración por TEP-TC EMA Recommends Granting a Marketing Authorisation for Inavolisib ¿Qué son los biosimilares para el tratamiento del cáncer? Making Transformative Advances against Childhood Cancer: A Conversation with Dr. Doug...
